Transfer of Cardiac Mitochondria Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in a Preclinical Model of Ischemic Heart Disease.
Marie Luce VignaisJennyfer LevouxPierre SicardKhattar KhattarCatherine LozzaMarianne GervaisSafia MezhoudJean NakhleFrederic RelaixOnnik AgbulutJeremy FauconnierAnne-Marie RodriguezPublished in: Cells (2023)
The preconditioning of MSCs with the artificial transfer of cardiac mitochondria appears to be promising strategy to improve the efficacy of MSC-based cell therapy in ischemic heart disease.